An experimental vaccine from researchers at the University of Oxford and Maryland biotech Novavax was shown to be strongly effective against malaria, a promising finding against one of the world's most deadly diseases, according to pre-printed study results published with The Lancet on Friday.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2025,